Neuland Laboratories reports 12% rise in Q2 net profit

11 Nov 2013 Evaluate

Neuland Laboratories has reported results for the second quarter ended September 30, 2013.

The company has reported 11.68% rise in its net profit at Rs 3.44 crore for the quarter as compared to Rs 3.08 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 10.97% at Rs 105.09 crore for quarter under review as compared to Rs  118.04 crore for the quarter ended September 30, 2012.

Neuland Laboratories is engaged in manufacturing of Salbutamol Sulphate. The company has has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions.

Neuland Laboratories Share Price

16903.35 -85.15 (-0.50%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×